Argent Biopharma【RGT】銘柄情報

Argent Biopharma Ltd (RGT) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.037

( - )

買値

0.037

売値

0.036

出来高

0.00

0.00 日の範囲 0.00

0.033 52 週間の範囲 0.32

時価総額

3.085M

前日終値

0.037

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 71,835

発行済株式数

83,384,867

配当利回り

PER

-0.3

1 株当たり利益 (EPS)

-0.12

歳入

347.78k

純利益

-8.62M

Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company’s principal product candidates include CimetrA, which is in phase ... Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company’s principal product candidates include CimetrA, which is in phase III clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy; and CogniCann, which is in phase IIA clinical trial for the symptomatic relief of Dementia and Alzheimer’s. It is also involved in the preclinical development of Irnican for the treatment of Glioblastoma Multiforme; and R&D, which focuses on wound treatment. The company has collaborated with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care. The company was formerly known as MGC Pharmaceuticals Limited and changed its name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

argentbiopharma.com

本社

Subiaco, Australia

設立

2026

Argent Biopharma Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker RGT. The last closing price for Argent Biopharma was AUD0.04. Over the last year, Argent Biopharma shares have traded in a share price range of AUD 0.033 to AUD 0.32.

Argent Biopharma currently has 83,384,867 shares in issue. The market capitalisation of Argent Biopharma is AUD3.09 million. Argent Biopharma has a price to earnings ratio (PE ratio) of -0.30.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.001	-2.63157894737	0.038	0.038	0.036	87934	0.03661855	DE
4	-0.003	-7.5	0.04	0.04	0.034	53155	0.03637469	DE
12	-0.001	-2.63157894737	0.038	0.054	0.033	73711	0.03843502	DE
26	-0.033	-47.1428571429	0.07	0.08	0.033	129372	0.0516839	DE
52	-0.047	-55.9523809524	0.084	0.32	0.033	113098	0.07303621	DE
156	-0.358	-90.6329113924	0.395	0.57	0.033	72704	0.12085559	DE
260	-0.358	-90.6329113924	0.395	0.57	0.033	72704	0.12085559	DE